Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease

Thyroid eye disease (TED) is a challenging autoimmune disorder that often requires therapeutic intervention. Glucocorticoids (GCs), particularly in intravenous (IV) regimens, remain the first-line treatment due to their strong anti-inflammatory and immunosuppressive effects. This paper focuses on t...

Full description

Bibliographic Details

Published in:	Quality in Sport
Main Authors:	Julia Ryniecka, Maciej Wojszczyk, Damian Zys, Piotr Pasek, Julia Kulbacka, Michalina Wójcikiewicz, Marta Chuncia-Ileczko, Julia Kacperczyk, Filip Arczewski, Karol Dziedzic
Format:	Article
Language:	English
Published:	Nicolaus Copernicus University in Toruń 2025-01-01
Subjects:	Thyroid eye disease (TED) glucocorticoids (GCs) mild TED moderate-to-severe TED sight-threatening TED intravenous glucocorticoids (IVGCs)
Online Access:	https://apcz.umk.pl/QS/article/view/57699